Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Rural china study aims to catch heart failure early in seniors with irregular heartbeat

NCT ID NCT07611084

First seen May 28, 2026 · Last updated Jun 19, 2026 · Updated 2 times

Summary

This study will follow 2,500 elderly people (ages 65-80) in rural China who have atrial fibrillation, a common heart rhythm problem. Researchers will screen them for heart failure using blood tests and heart ultrasounds, then check on them every three months to see how their condition changes over time. The goal is to better understand and detect heart failure early in this underserved population.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Department of Cardiology

    RECRUITING

    Taizhou, Jiangsu, 225300, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could improve early detection of heart failure in rural elderly patients with atrial fibrillation, potentially reducing hospitalizations and deaths.

What could go wrong

This is an observational study, not a treatment trial. It may not lead to direct health improvements, and results may not apply to other populations or settings.

Conditions

The condition(s) this trial relates to.

atrial fibrillation Disease Progression heart failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.